Impact of type of reduced‐intensity conditioning regimen on the outcomes of allogeneic haematopoietic cell transplantation in classical Hodgkin lymphoma-Reference-Cited by-同舟云学术

Impact of type of reduced‐intensity conditioning regimen on the outcomes of allogeneic haematopoietic cell transplantation in classical Hodgkin lymphoma

Published:2020-04-21 Issue:4 Volume:190 Page:573-582
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Ahmed Sairah¹,Ghosh Nilanjan²,Ahn Kwang W.³⁴,Khanal Manoj³,Litovich Carlos³,Mussetti Alberto⁵⁶,Chhabra Saurabh³⁷^ORCID,Cairo Mitchell⁸^ORCID,Mei Matthew⁹,William Basem¹⁰^ORCID,Nathan Sunita¹¹,Bejanyan Nelli¹²,Olsson Richard F.¹³¹⁴,Dahi Parastoo B.¹⁵,Poel Marjolein¹⁶,Steinberg Amir¹⁷,Kanakry Jennifer¹⁸,Cerny Jan¹⁹,Farooq Umar²⁰^ORCID,Seo Sachiko²¹,Kharfan‐Dabaja Mohamed A.²²^ORCID,Sureda Anna²³^ORCID,Fenske Timothy S.⁷,Hamadani Mehdi³⁷^ORCID

Affiliation:

1. MD Anderson Cancer Center University of Texas Houston TX USA

2. Department of Hematologic Oncology and Blood Disorders Levine Cancer Institute Atrium Health Charlotte NC USA

3. Department of Medicine CIBMTR® (Center for International Blood and Marrow Transplant Research) Medical College of Wisconsin Milwaukee WI USA

4. Division of Biostatistics Institute for Health and Equity Medical College of Wisconsin Milwaukee WI USA

5. Hematology Department Institut Catalá d'Oncologia – Hospitalet Barcelona Spain

6. IDIBELL‐Institut Català d'Oncologia, l'Hospitalet de Llobregat El Prat de Llobregat Spain

7. Division of Hematology and Oncology Department of Medicine Medical College of Wisconsin Milwaukee WI USA

8. Division of Pediatric Hematology, Oncology and Stem Cell Transplantation Department of Pediatrics New York Medical College Valhalla NY USA

9. City of Hope Duarte CA USA

10. Division of Hematology The Ohio State University Columbus OH USA

11. Rush University Medical Center Chicago IL USA

12. Department of Blood and Marrow Transplant and Cellular Immunotherapy Moffitt Cancer Center Tampa FL USA

13. Department of Laboratory Medicine Karolinska Institutet Stockholm Sweden

14. Centre for Clinical Research Sormland Uppsala University Uppsala Sweden

15. Department of Medicine, Adult Bone Marrow Transplant Service Memorial Sloan Kettering Cancer Center New York NY USA

16. Maastricht University Medical Centre Maastricht the Netherlands

17. Division of Hematology and Oncology Mount Sinai Hospital New York NY USA

18. National Cancer Institute‐ NIH Bethesda MD USA

19. Divsion of Hematology/Oncology Department of Medicine University of Massachusetts Medical Center Worcester MA USA

20. Division of Hematology, Oncology and Blood & Marrow Transplantation University of Iowa Hospitals and Clinics Iowa City IA USA

21. Department of Hematology and Oncology Dokkyo Medical University Tochigi Japan

22. Division of Hematology‐Oncology, Blood and Marrow Transplantation Program Mayo Clinic Jacksonville FL USA

23. Hematology Department Institut Català d'Oncologia – Hospitalet IDIBELL University of Barcelona Barcelona Spain

Funder

National Cancer Institute

Office of Naval Research

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.16664

Reference37 articles.

1. T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for Hodgkin Lymphoma Relapsed after Autologous Transplantation: Reduced Incidence of Relapse and of Chronic Graft-versus-Host Disease Compared with HLA-Identical Related Donors

2. Autologous Stem-Cell Transplantation for Hodgkin’s Disease: Results and Prognostic Factors in 494 Patients From the Grupo Español de Linfomas/Transplante Autólogo de Médula Ósea Spanish Cooperative Group

3. A prognostic model predicting autologous transplantation outcomes in children, adolescents and young adults with Hodgkin lymphoma

4. Superiority of reduced-intensity allogeneic transplantation over conventional treatment for relapse of Hodgkin's lymphoma following autologous stem cell transplantation

5. Allogeneic transplantation for Hodgkin’s lymphoma

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hodgkin lymphoma: 2025 update on diagnosis, risk‐stratification, and management;American Journal of Hematology;2024-09-06

2. Reduced‐intensity conditioning with fludarabine/busulfan versus fludarabine/low‐dose melphalan in patients with non‐Hodgkin lymphoma undergoing allogeneic haematopoietic stem cell transplantation;British Journal of Haematology;2024-07-24

3. Impact of Different Fludarabine Doses in the Fludarabine-Based Conditioning Regimen for Unrelated Bone Marrow Transplantation;Transplantation and Cellular Therapy;2024-05

4. Remission of relapsed/refractory classical Hodgkin lymphoma induced by brentuximab vedotin and pembrolizumab combination after allogeneic hematopoietic stem cell transplantation: a case report;Frontiers in Immunology;2024-03-06

5. Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024